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Mycobacterium bovis, one of several mycobacteria of the
M. tuberculosis complex, is a global zoonotic pathogen that primarily infects cattle. Humans become infected by consuming
unpasteurized dairy products from infected cows (1,2); possible
person-to-person airborne transmission has also been reported
(3). In April 2014, a man in Nebraska who was born in Mexico
was determined to have extensive pulmonary tuberculosis (TB)
caused by M. bovis after experiencing approximately 3 months
of cough and fever. Four months later, a U.S.-born Hispanic
girl from a nearby town who had been ill for 4–5 months was
also determined to have pulmonary TB caused by M. bovis.
The only social connection between the two patients was
attendance at the same church, and no common dietary
exposure was identified. Both patients had pulmonary cavities
on radiography and acid-fast bacilli (AFB) on sputum-smear
microscopy, indicators of being contagious (4). Whole-genome
sequencing results of the isolates were nearly indistinguishable.
Initial examination of 181 contacts determined that 39 (22%)
had latent infection: 10 (42%) of 24 who had close exposure
to either patient, 28 (28%) of 100 who were exposed to one
or both patients in church, and one (2%) of 57 exposed to the
second patient at a school. Latent infection was diagnosed in
six contacts on follow-up examination, 2 months after an initial
negative test result (4), for an overall latent infection rate of
25%. No infected contacts recalled consuming unpasteurized
dairy products, and none had active TB disease at the initial or
secondary examination. Persons who have M. bovis TB should
be asked about consumption of unpasteurized dairy products
(2), and contact investigations should follow the same guidance
as for M. tuberculosis TB (4).
In April 2014, patient A, a man aged 42 years who was
born in Mexico sought care for cough, fever, weight loss, and
progressive debilitation over approximately 3 months. He had

arrived in Nebraska from Mexico in 2010, and initially he
worked on a dairy farm* and later in construction. No information was collected regarding his prior employment in Mexico,
but he did report frequent consumption of raw milk. Chest
radiography was consistent with advanced TB with cavities;
numerous AFB were reported from sputum-smear microscopy.
The result from nucleic acid amplification testing of sputum
was positive for M. tuberculosis complex. The isolate was resistant both to pyrazinamide (PZA), which suggested that the
* Nebraska dairies have been free of M. bovis infections since 1978. In recent
years, M. bovis infections have been detected sporadically among Nebraska beef
herds (late 1990s, 2005, 2009, and 2013) and an elk herd (2009) (Nebraska
Department of Agriculture, unpublished data, June 29, 2015). No persons in
this investigation were thought to have had contact with these sources. The
whole-genome sequencing results for all veterinary M. bovis isolates from
Nebraska are distinct from those of both patients’ isolates.
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infection was caused by M. bovis, and to low-concentration
isoniazid (INH) (5). His treatment regimen was adjusted in
consultation with national experts in drug-resistant TB. He
recovered slowly and remained isolated at home until results
from sputum smears were negative for AFB in August.
In June 2014, patient B, a Hispanic girl aged 16 years, who
was born in Nebraska to Mexican parents, sought medical care
after 2–3 months of cough. She initially received treatment for
presumed bronchitis and allergies, without chest radiography.
She remained ill through late July, when radiography revealed
a pulmonary cavity and her sputum smear had numerous
AFB. M. bovis resistant to PZA was identified after culture
confirmation. She had never traveled outside the United States
and was unaware of having consumed any dairy products from
Mexico. She recovered quickly and remained in isolation at
home until late September. The only social connection between
patients A and B was regular attendance at the same church.
The patients knew one another but their interactions were
reported to be minimal.
Contact investigations were conducted in accordance with
published guidelines (4) focusing on household contacts of
both patients, community contacts at both the church and
patient B’s school, coworkers of patient A, and persons who
spent extended periods in a vehicle with him. Potentially
exposed health care workers were notified for follow-up at their
respective facilities with a request to report infections to the
health department if identified. Tuberculin skin tests (TST)

and interferon gamma release assays (IGRA) were used for testing U.S.-born and foreign-born contacts, respectively; IGRA
was used for all members of the church, where the majority
of contacts were foreign born. Contacts whose initial results
were negative, but whose exposure to either patient had ended
<2 months before testing, were retested after 8–12 weeks,
because immune sensitivity might not be detectable during this
period after new infection (4). Persons who had positive test
results indicating infection had chest radiographs to exclude
active TB disease and thus establish latent infection (4).† All
contacts were asked about their country of birth except those
at a school attended by patient B where all were assumed to
have been born in the United States. Midway through the
investigation, after M. bovis was recognized as the causative
agent, contacts who had positive test results were also asked
about travel abroad and consumption of unpasteurized dairy
products from Mexico.
† Tuberculosis

infection is “a condition in which microorganisms [i.e.,
M. tuberculosis complex] have entered the body and typically have elicited
immune responses” and “includes both latent infection and TB disease.” Latent
infection “is an asymptomatic condition that follows the initial infection; the
infection is still present but is dormant (and believed not to be currently
progressive or invasive)” and “might progress to TB disease.” “[Active] TB
disease is determined by finding anatomic changes caused by advancing infection
(e.g., shadows from infiltrates on a chest radiograph) or by noting symptoms
(e.g., malaise, feverishness, or cough), and typically by both.” http://www.cdc.
gov/mmwr/preview/mmwrhtml/rr5415a2.htm.
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Twenty-four persons had extended close exposure to either
patient and were regarded as high-priority contacts (4); among
these, 10 (42%) had positive results at initial testing (Table 1).
Two were non-Hispanic U.S.-born contacts of patient A who
did not attend the church. Among 11 high-priority contacts
of patient B, seven were family members who were also potentially exposed to patient A at the church. Among patient B’s
five siblings, four were born in the United States, had never
traveled abroad, and did not recall consuming dairy products from Mexico; three of these four siblings were infected.
Patient B’s eldest sibling and mother, both of whom were born
in Mexico, were also infected but neither had active TB disease
and thus would not have been infectious. Among 100 church
members (excluding patient B and high-priority contacts of
either patient), 28 (28%) had latent infection, including five
U.S.-born children. Among 57 school contacts, one U.S.-born
child was infected. No infections among exposed health care
workers were reported.
Among 77 persons for whom retesting was indicated, 56
(73%) were retested, and six (11%) were determined to have
latent infection (Table 2). During the interval between the first
and second tests, none had traveled abroad or recalled eating
unpasteurized dairy products from Mexico. No school contacts
were retested, because their exposure had ended the previous
May. No infected contacts had active TB disease, and all were
offered a 4-month rifampin preventive regimen.§
Patient A’s bacterial isolate, grown at a private hospital laboratory from a sputum sample collected April 24, 2014, was sent to
the Nebraska Public Health Laboratory to facilitate genotyping
at the Michigan state laboratory and first-line drug susceptibility testing at Associated Regional and University Pathologists,
Inc.; second-line drug susceptibility testing was conducted
at CDC. Patient B’s isolate was cultured by Nebraska Public
Health Laboratory from a sputum sample collected during
early August, and it was similarly sent for first- and second-line
drug susceptibility testing and genotyping. Routine genotyping results of both patients’ isolates were indistinguishable. In
late September 2014, both patients’ isolates were sent to the
United States Department of Agriculture National Veterinary
Services Laboratories (NVSL) where whole-genome sequencing
was performed. Results suggested that the two patients’ isolates
were closely related; phylogenetic comparisons differed by only
three single nucleotide polymorphisms (SNPs). The sequences
§ In

August 2015, a U.S.-born 11-year-old niece of patient A, who reported
exposure to him only at the church, became ill with shortness of breath and
cough. During the church contact investigation, she and her parents were
determined to have latent infection, but they had stopped taking rifampin after
only 2 months. A presumptive diagnosis of TB disease caused by M. bovis was
made, and treatment was started in September 2015, based on clinical findings,
including a new pulmonary infiltrate (4,6). Results from sputum-smear
microscopy, nucleic acid amplification test, and culture were negative.

did not match others in NVSL’s library, but the isolates shared
a common ancestor with isolates from five cattle in Mexico.¶
Discussion

M. bovis primarily causes disease in cattle but also infects
deer and other mammals (1). The human diseases caused by
M. bovis and M. tuberculosis (i.e., the human variant) are clinically indistinguishable, and cases caused by both are reported
in U.S. TB surveillance (1,2,6,7).** Treatment differs, however, because M. bovis is inherently resistant to PZA, which is
part of the routine initial TB treatment regimen (5). Bovine
tuberculosis eradication programs and routine pasteurization
of milk products have led to marked declines in M. bovis TB
in humans (1), which accounted for 1.6% of U.S. TB cases in
2014 (6), with regional differences (2,6–8).
Human M. bovis disease is typically attributed to consumption of unpasteurized milk (or dairy products made from
unpasteurized milk) in or imported from countries with
affected cattle herds (1,2,7,8). Person-to-person airborne
transmission of M. bovis has been reported infrequently, with
uncertainty remaining about dietary exposures (3). Findings
from contact investigations and a population study regarding
infectiousness of M. bovis compared with M. tuberculosis are
inconclusive (4,9,10).††
Standard nucleic acid amplification test methods detect
the M. tuberculosis complex without distinguishing between
M. tuberculosis and M. bovis. Although these species can be distinguished by routine genotyping, biochemical characterization
and drug susceptibility testing, which generally provide results
earlier, have been historically used and can increase the index
of suspicion for M. bovis. Whole-genome sequencing can be
used to identify species and investigate transmission. NVSL
sequences genomes for all U.S. M. bovis animal isolates, a
convenience sample of cattle isolates from Mexico, and human
isolates upon request.§§
¶

These cattle included four dairy cows in Nuevo León and one steer in Durango,
Mexico. On the basis of whole-genome sequencing of 15 less related cattle
isolates in Group 13, this M. bovis strain appears to be disseminated throughout
Mexico but has not been identified in U.S.-origin cattle. Isolates in this group
of the SB0121 family are believed to have evolved on the Iberian Peninsula.
** Genotyping results from CDC’s National TB Genotyping Service for the
isolates from 96 TB patients with culture-confirmed disease in Nebraska
during 2006–2013 indicated that all were M. tuberculosis.
†† Infectious TB “refers either to TB disease of the lungs or throat, which has the
potential to cause transmission to other persons, or to the patient who has TB
disease.” http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5415a2.htm.
§§ NVSL has sequenced 97% of M. bovis isolates from affected U.S. cattle herds
since 1997 and 90% from feeder and feedlot cattle (both imported and
domestic) since 2000. The oldest isolate sequenced is from 1991, but isolates
were not consistently archived from affected herds until 1997. NVSL sequences
the M. bovis isolates from all animal species; the size of the database is
approximately 2,500 sequences.
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TABLE 1. Investigation setting and results of initial testing* of contacts (N = 181) exposed to one or both of two Mycobacterium bovis tuberculosis
patients, by United States versus foreign birth — Nebraska, 2014
Test results negative
Investigation setting†
High-priority contacts of patient A
High-priority contacts of patient B
Church
Patient B’s school
Total

Test results positive

Foreign-born

U.S.-born

Total negative

Foreign-born

U.S.-born

Total positive

Total tested

No. (%)

No. (%)

No. (%)

No. (%)

No. (%)

No. (%)

No.

3 (23)
2 (18)
23 (23)
0 (0)
28†† (15)

2§ (15)
3¶ (27)

5 (38)
5 (45)
28 (28)
1 (2)
39§§ (22)

13
11
100
57
181

3 (23)
2 (18)
43 (43)
NA
NA

5 (38)
4 (36)
29 (29)
NA
NA

8 (62)
6 (55)
72 (72)
56 (98)
142 (78)

5** (5)
1** (2)
11 (6)

Abbreviation: NA = not available.
* Tuberculin skin tests and interferon gamma release assays (IGRA) were used for testing U.S.-born and foreign-born contacts, respectively; IGRA was used for all
members of the church where the majority of contacts were foreign born.
† The counts in the four categories of settings are mutually exclusive. Among the 13 high-priority contacts of patient A, 11 did not attend the church. Among the
remaining two who were also potentially exposed to patient B at the church, one tested positive (patient B’s grandfather). Among the 11 high-priority contacts of
patient B, all were also potentially exposed to patient A at the church. Patients A and B were not counted as contacts for any setting.
§ Non-Hispanic U.S.-born adults exposed at patient A’s residence.
¶ Three Hispanic siblings of patient B (aged 7, 9, and 10 years).
** Six U.S.-born children. Unknown travel and dietary history.
†† Countries of birth are Mexico (n = 26), Guatemala (n = 1), and Philippines (n = 1).
§§ All 39 persons testing positive reported no knowledge of a prior positive TB test result, but information was lacking to verify the accuracy of their recall.

TABLE 2. Investigation setting and results of follow-up testing*
performed 8–12 weeks after last potential exposure and after
an initial negative result for contacts (N = 56) of one or both of
two Mycobacterium bovis tuberculosis patients — Nebraska,
October 2014
Test results
negative

Test results
positive

Total

Investigation setting†

No. (%)

No. (%)

No.

High-priority contacts of patient A
High-priority contacts of patient B
Church
Total

0 (0)
1 (25)
49 (96)
50 (89)

1§ (100)
3¶ (75)
2 (4)
6** (11)

1
4
51
56

* An interferon-gamma release assay was used for testing at the church where
foreign-born persons predominated and for other foreign-born contacts.
Tuberculin skin tests were used for U.S.-born contacts.
† Follow-up testing was not necessary for contacts at patient B’s school because
the end of their exposure was >2 months before the investigation.
§ Non-Hispanic U.S.-born individual exposed at patient A’s residence who
reported no international travel at any time and no consumption of Mexicoorigin unpasteurized dairy products. This person had no affiliation with the
church or the school and reported no contact with patient B, who resided in
a different town.
¶ All three were patient B’s family members who were also potentially exposed
to patient A at the church.
** All six denied both international travel and consumption of Mexico-origin
unpasteurized dairy products in the interim. Among these, three were foreign
born (two high-priority contacts of patient B and one church member).

Patient A might have been infected from consuming unpasteurized dairy products originating in Mexico. The timing of
the illnesses, relatedness of the M. bovis isolates, and common
church attendance suggest that patient B might have acquired
infection from patient A. Findings from the contact investigations suggest possible airborne transmission, because approximately one third of the infections could not be explained
by potential exposure in countries where M. tuberculosis
complex infections are common. Consumption of imported
200
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contaminated dairy products could not be excluded, but locally
produced dairy products were unlikely to be contaminated
with M. bovis.
The findings in this report are subject to at least four limitations. This investigation illustrates typical challenges of investigating human M. bovis infections. First, the incubation period
has not been well studied, but it potentially ranges from months
to years and might obscure ascertainment of time and nature
of exposure. Second, dietary history details could be forgotten
during the interim, or consumers might be unaware of the origin or pasteurization status of dairy products they consumed.
Third, TST and IGRA are based on cellular immune response
and cannot distinguish between old or recent infections, or
whether the cause is M. tuberculosis or M. bovis. Persons from
countries where both types of infection are prevalent could
be infected by either species. The variable incubation period
for M. bovis notwithstanding, the six persons whose results
changed from negative to positive were probably infected only
in the weeks before being examined. Finally, despite not documenting conversion in the first five U.S.-born high-priority
contacts who were infected, this observed proportion of latent
infections (29% [five of 17]) upon initial testing exceeds the
expected background prevalence of latent infection of <2%
for persons born in the United States.
An evidence base to aid epidemiologic interpretation of
whole-genome sequencing results from isolates with few
differences in SNPs has not been established for M. bovis or
M. tuberculosis. Maintenance of patient A’s isolate in culture
for approximately 5 months could have provided opportunity
for accrual of the additional SNPs. Airborne transmission from
either patient was plausible based on disease characteristics
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Summary
What is already known about this topic?
Mycobacterium bovis, a zoonotic pathogen of cattle, causes
tuberculosis in persons who consume unpasteurized contaminated dairy products. Airborne person-to-person transmission
has been suspected but is difficult to confirm.
What is added by this report?
A large contact investigation around two patients with M. bovis
pulmonary tuberculosis and the findings from molecular
epidemiology strengthen the evidence for person-to-person
transmission of M. bovis infection.
What are the implications for public health practice?
The persistence of M. bovis in cattle internationally and the failure
to pasteurize dairy products in many locations means that further
infections in humans should be anticipated. Persons with M. bovis
infections should be asked about foodborne exposures. Contact
investigations for M. bovis disease should be conducted using the
same methods as for M. tuberculosis disease.

(i.e., pulmonary cavities and AFB on sputum smears) and
contact findings.
This report adds to the evidence for airborne person-toperson spread of M. bovis (3,9,10). Whole-genome sequencing
is an emerging tool for investigating transmission. Public health
responses to M. bovis pulmonary TB should be the same as
those for M. tuberculosis TB, with additional inquiries about
consumption of unpasteurized dairy products. The ongoing
incidence of M. bovis TB in humans substantiates the need to
control bovine tuberculosis globally and to pasteurize all milk
and dairy products.
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